InVivo Theraptc (NASDAQ:NVIV) has today made an exciting announcement. According to most recent INSPIRE assessments, those patients who were in the INSPIRE study of the Neuro-Spinal Scaffold showcased significant improvements from the sensory incomplete AIS B spinal cord injury (SCI) to motor incomplete AIS C SCI. According to some top sources, these happen to be the second and third patients in the INSPIRE study that managed to reach the AIS C motor incomplete classification.

 May 2016 witnessed the enrollment of one of these patients and the three-month exam saw the patient converted from complete AIS A SCI to incomplete AIS B SCI. During the 12-month visit, this patient was able to regain the motor function linked to most of the sacral segments of the spinal cord whose assessment turned out to be AIS C.

The Principal Investigator at Vidant Medical Center in Greenville, Stuart Lee while addressing a number of journalists said, “The patient’s continued improvement at the one year exam is encouraging. Return of sacral motor function may be related to improvements in bowel and bladder function that can have an appreciable impact on a patient’s quality of life. We look forward to monitoring this patient’s recovery and hope for continued progress.”

In June 2015, another patient got enrolled and the study was conducted appropriately. The 24-month per protocol ISNCSCI exam led to the discovery that AIS C indicated remarkable capabilities to contract two muscles of one leg.

Dr. Bockenek revealed that this particular patient was within a short period of time able to move from AIS A to AIS B. This is indeed a desirable change. However, it is crucial to point out that the clinical significance of this change remains unknown. One of the top experts has asserted that they remain cautiously optimistic that indeed some possibilities for more changes still lie ahead.

Mark Perrin, the InVivo CEO according to Yahoo has expressed great excitement in relation to the fact that the two patients continued to progress beyond the period of early improvement.